Chemotherapy Combines With Bevacizumab and PD-1 Inhibitor in Non-squamous NSCLC
Clinical trial NCT05267366 · UNKNOWN
Trial details
- NCT number
- NCT05267366
- Sponsor
- Qingdao Central Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-01
- Primary completion
- 2024-02-01
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.